Replies to post #119072 on Biotech Values

[DewDiligence]

Judge sides with Ranbaxy/FDA—against MYL—in generic-Lipitor suit:

http://www.bloomberg.com/news/2011-05-03/mylan-lawsuit-over-lipitor-copy-thrown-out-by-federal-judge-1-.html

This is good news not only for Ranbaxy, but also for PFE and WPI (which has rights to launch an AG).